Amena Mahdami

HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients

R. Hamoudi, K. Bajbouj, M. Rahmani, 2021, The Libyan journal of medicine.

Genetic analysis of CFH and MCP in Egyptian patients with immune-complex proliferative glomerulonephritis

R. Hamoudi, H. Busch, N. Baddour, 2022, Frontiers in Immunology.

Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer.

P. Neven, C. Desmedt, H. Wildiers, 2023, European journal of cancer.